BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11961407)

  • 21. [Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis].
    Yang HD; Dong C; Guan FJ; Gao LL; Zhao T; Feng BF
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):483-7. PubMed ID: 20540862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The altered glomerular filtration slits seen in puromycin aminonucleoside nephrosis and protamine sulfate-treated rats contain the tight junction protein ZO-1.
    Kurihara H; Anderson JM; Kerjaschki D; Farquhar MG
    Am J Pathol; 1992 Oct; 141(4):805-16. PubMed ID: 1415478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cloning, expression, and distribution of glomerular epithelial protein 1 in developing mouse kidney.
    Wang R; St John PL; Kretzler M; Wiggins RC; Abrahamson DR
    Kidney Int; 2000 May; 57(5):1847-59. PubMed ID: 10792603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of VEGF and its receptors in two rat models of proteinuria.
    Kanellis J; Levidiotis V; Khong T; Cox AJ; Stacker SA; Gilbert RE; Cooper ME; Power DA
    Nephron Physiol; 2004; 96(1):P26-36. PubMed ID: 14752241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
    Wang JS; Yang AH; Chen SM; Young TK; Chiang H; Liu HC
    Nephron; 1993; 65(3):418-25. PubMed ID: 8289993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
    Ebihara I; Nakamura T; Tomino Y; Koide H
    Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Podocin is translocated to cytoplasm in puromycin aminonucleoside nephrosis rats and in poor-prognosis patients with IgA nephropathy.
    Fukuda H; Hidaka T; Takagi-Akiba M; Ichimura K; Oliva Trejo JA; Sasaki Y; Wang J; Sakai T; Asanuma K; Tomino Y
    Cell Tissue Res; 2015 May; 360(2):391-400. PubMed ID: 25676004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between glomerular function and podocyte structure of pre-proteinuria and acute nephrosis in puromycin aminonucleoside-induced rat models: a comparative electron microscopic study.
    Seçkin İ; Uzunalan M; Pekpak M; Köktürk S; Sönmez HA; Güngör ZB; Demirkiran ÖD; Saygi Hİ; Yaprak Saraç E
    Rom J Morphol Embryol; 2017; 58(3):823-830. PubMed ID: 29250660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
    Yang Y; Gubler MC; Beaufils H
    Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
    Holthöfer H; Reivinen J; Solin ML; Haltia A; Miettinen A
    Am J Pathol; 1996 Sep; 149(3):1009-15. PubMed ID: 8780404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of CD54, CD18, MHC class II molecules, and proliferating cell nuclear antigen in acute puromycin aminonucleoside nephrosis.
    Fernandez L; Romero M; Rincón J; Mosquera J
    Nephron Exp Nephrol; 2003; 94(2):e55-65. PubMed ID: 12845231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
    Lee YK; Kwon T; Kim DJ; Huh W; Kim YG; Oh HY; Kawachi H
    Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In glomerular cells of puromycin aminonucleoside nephrosis rats both phosphorylated and total STAT3 levels increased during proteinuria.
    Saygı Hİ; Güngör ZB; Kalay F; Seçkin İ
    Acta Histochem; 2018 Aug; 120(6):595-603. PubMed ID: 30054017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephrin and podocin expression around the onset of puromycin aminonucleoside nephrosis.
    Hosoyamada M; Yan K; Nishibori Y; Takiue Y; Kudo A; Kawakami H; Shibasaki T; Endou H
    J Pharmacol Sci; 2005 Feb; 97(2):234-41. PubMed ID: 15684566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.
    Matsui I; Hamano T; Tomida K; Inoue K; Takabatake Y; Nagasawa Y; Kawada N; Ito T; Kawachi H; Rakugi H; Imai E; Isaka Y
    Nephrol Dial Transplant; 2009 Aug; 24(8):2354-61. PubMed ID: 19297354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Permeability, ultrastructural changes, and distribution of novel proteins in the glomerular barrier in early puromycin aminonucleoside nephrosis.
    Dunér F; Lindström K; Hultenby K; Hulkko J; Patrakka J; Tryggvason K; Haraldsson B; Wernerson A; Pettersson E
    Nephron Exp Nephrol; 2010; 116(2):e42-52. PubMed ID: 20588063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in the distribution of plasma fibronectin and the ultrastructure of podocytes in the peripheral glomerular loops in nephrotic rats.
    Kubosawa H; Kondo Y
    Virchows Arch; 1998 Nov; 433(5):449-55. PubMed ID: 9849860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of synaptopodin and GLEPP1 as markers of steroid responsiveness in primary focal segmental glomerulosclerosis.
    Hirakawa M; Tsuruya K; Yotsueda H; Tokumoto M; Ikeda H; Katafuchi R; Fujimi S; Hirakata H; Iida M
    Life Sci; 2006 Jul; 79(8):757-63. PubMed ID: 16564554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Podocyte proteins in Galloway-Mowat syndrome.
    Srivastava T; Whiting JM; Garola RE; Dasouki MJ; Ruotsalainen V; Tryggvason K; Hamed R; Alon US
    Pediatr Nephrol; 2001 Dec; 16(12):1022-9. PubMed ID: 11793093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats.
    Ricardo SD; Bertram JF; Ryan GB
    J Am Soc Nephrol; 1994 Jun; 4(12):1974-86. PubMed ID: 7919151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.